CN Stock MarketDetailed Quotes

002788 Luyan Pharma

Watchlist

8.17
+0.02+0.25%

Market Closed May 9 15:00 CST

3.17BMarket Cap9.52P/E (TTM)

Luyan Pharma Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q3)Mar 31, 2025

(FY)Dec 31, 2024

(Q9)Sep 30, 2024

(Q6)Jun 30, 2024

(Q3)Mar 31, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

(Q3)Mar 31, 2023

(FY)Dec 31, 2022

Total operating revenue

0.74%5.17B

3.15%20.47B

4.32%15.41B

2.81%10.31B

6.08%5.14B

1.97%19.85B

3.15%14.78B

7.32%10.02B

4.40%4.84B

10.93%19.46B

Operating revenue

0.74%5.17B

3.15%20.47B

4.32%15.41B

2.81%10.31B

6.08%5.14B

1.97%19.85B

3.15%14.78B

7.32%10.02B

4.40%4.84B

10.93%19.46B

Other operating revenue

----

20.10%72.73M

----

-6.47%24.82M

----

7.03%60.56M

----

3.13%26.54M

----

52.24%56.58M

Total operating cost

1.06%5.07B

3.31%20B

4.26%15.05B

2.64%10.04B

6.07%5.02B

2.19%19.36B

3.36%14.44B

7.54%9.78B

4.38%4.73B

10.73%18.95B

Operating cost

1.14%4.81B

3.33%18.95B

4.34%14.28B

2.73%9.53B

6.22%4.76B

2.17%18.34B

3.39%13.69B

7.68%9.28B

4.22%4.48B

10.96%17.95B

Operating tax surcharges

0.96%11.14M

10.58%48.16M

12.99%34.07M

17.29%23.29M

10.78%11.04M

3.04%43.55M

2.34%30.16M

1.16%19.86M

9.95%9.96M

7.81%42.26M

Operating expense

1.65%116.72M

5.94%467.94M

5.02%341.69M

2.79%224.48M

8.84%114.82M

2.07%441.71M

5.03%325.35M

7.49%218.38M

6.21%105.49M

14.09%432.77M

Administration expense

0.58%78.46M

3.87%321.24M

4.89%234.67M

1.79%154.21M

3.65%78.01M

3.51%309.28M

1.33%223.74M

4.31%151.49M

7.85%75.26M

-7.17%298.78M

Financial expense

-7.01%49.04M

-5.06%211.63M

-6.99%155.39M

-6.81%103.16M

-8.91%52.73M

1.30%222.91M

0.77%167.06M

1.58%110.7M

8.13%57.89M

15.01%220.05M

-Interest expense (Financial expense)

-5.50%47.98M

-7.26%206.68M

1.29%152.95M

0.27%101.71M

-0.47%50.78M

1.71%222.85M

1.08%151M

3.24%101.44M

8.70%51.02M

15.15%219.1M

-Interest Income (Financial expense)

82.31%-184.1K

25.37%-3.84M

17.61%-3.01M

44.08%-2.1M

16.62%-1.04M

-33.27%-5.14M

11.67%-3.66M

-48.82%-3.75M

-34.98%-1.25M

25.53%-3.86M

Research and development

12.15%1.37M

5.63%5.85M

28.23%3.64M

41.26%2.74M

58.31%1.22M

33.47%5.53M

-0.77%2.84M

38.41%1.94M

27.61%769.3K

39.51%4.15M

Credit Impairment Loss

28.66%-8.76M

94.47%-813.09K

4.17%-17.52M

-35.85%-14.86M

-2.20%-12.28M

70.15%-14.71M

13.57%-18.28M

24.51%-10.94M

-17.29%-12.02M

-57.46%-49.3M

Asset Impairment Loss

79.07%-120.43K

27.36%-1.87M

49.98%-289.95K

227.46%418.83K

-426.72%-575.39K

17.53%-2.58M

88.66%-579.62K

92.46%-328.6K

95.94%-109.24K

55.64%-3.13M

Other net revenue

14.24%-12.71M

33.74%-11.61M

-56.48%-25.44M

-140.57%-18.06M

-26.33%-14.81M

65.76%-17.53M

34.44%-16.25M

58.61%-7.51M

4.32%-11.73M

-67.33%-51.19M

Fair value change income

----

--0

----

Invest income

-42.39%-5.06M

-54.09%-18.73M

-167.53%-12.98M

-459.42%-9.31M

-37.48%-3.55M

-75.66%-12.16M

-95.55%-4.85M

-17.43%-1.66M

-577.61%-2.58M

-224.12%-6.92M

Net open hedge income

----

--0

----

-Including: Investment income associates

---1.64M

-2,709.17%-4.33M

-320.97%-3.22M

---2.45M

----

-117.01%-154.29K

--1.46M

--0

--906.8K

Asset deal income

132.66%1.18K

-37.56%172.33K

158.46%67.99K

83.41%-25.15K

79.01%-3.61K

117.85%275.98K

-193.17%-116.29K

-214.01%-151.56K

-124.56%-17.21K

123.78%126.69K

Other revenue

-22.87%1.23M

-17.30%9.63M

-30.23%5.29M

2.60%5.72M

-46.78%1.6M

45.10%11.65M

97.82%7.58M

179.22%5.58M

202.17%3M

-23.08%8.03M

Operating profit

-12.24%92.6M

-2.23%458.1M

4.57%337.19M

5.48%245.22M

4.21%105.52M

0.56%468.56M

-2.66%322.45M

3.73%232.48M

6.53%101.26M

14.80%465.94M

Add:Non operating Income

276.16%927.43K

70.57%4.52M

10.94%1.36M

-4.26%1.12M

44.74%246.55K

-33.82%2.65M

-49.84%1.23M

-39.96%1.17M

-79.99%170.34K

-66.67%4.01M

Less:Non operating expense

332.83%982.79K

423.12%9.35M

409.21%4.75M

81.57%1.18M

7.31%227.06K

-54.66%1.79M

1.25%932.76K

29.82%651.06K

28.10%211.6K

46.46%3.94M

Total profit

-12.31%92.55M

-3.44%453.27M

3.43%333.8M

5.22%245.15M

4.27%105.54M

0.73%469.42M

-3.02%322.74M

3.29%233M

5.72%101.22M

12.23%466.01M

Less:Income tax cost

3.51%22.79M

0.62%105.58M

19.19%75.9M

26.77%54.39M

-2.67%22.02M

-8.79%104.93M

-21.21%63.68M

-23.58%42.9M

-7.32%22.62M

4.01%115.04M

Net profit

-16.49%69.76M

-4.61%347.7M

-0.45%257.9M

0.35%190.76M

6.26%83.52M

3.85%364.49M

2.82%259.06M

12.20%190.1M

10.19%78.6M

15.22%350.97M

Net profit from continuing operation

-16.49%69.76M

-4.61%347.7M

-0.45%257.9M

0.35%190.76M

6.26%83.52M

3.85%364.49M

2.82%259.06M

12.20%190.1M

10.19%78.6M

15.22%350.97M

Less:Minority Profit

-522.39%-1.57M

112.98%2.05M

119.00%554.29K

-63.90%390.67K

80.02%-252.02K

-83.43%964.06K

-365.49%-2.92M

64.19%1.08M

-238.00%-1.26M

562.10%5.82M

Net profit of parent company owners

-14.86%71.32M

-4.92%345.64M

-1.77%257.35M

0.72%190.37M

4.90%83.78M

5.32%363.53M

4.43%261.98M

12.00%189.01M

11.37%79.86M

12.84%345.16M

Earning per share

Basic earning per share

-18.18%0.18

-5.32%0.89

-1.49%0.66

0.00%0.49

4.76%0.22

5.62%0.94

3.08%0.67

13.95%0.49

16.67%0.21

12.66%0.89

Diluted earning per share

----

-1.49%0.66

----

--0.67

----

Other composite income

351.01%23.34K

-60.91%397.85K

-105.58%-67.89K

-18.11%1.09M

101.17%5.17K

-69.35%1.02M

-67.86%1.22M

-16.83%1.34M

-58.21%-441.71K

435.34%3.32M

Other composite income of parent company owners

351.01%23.34K

-60.91%397.85K

-105.58%-67.89K

-18.11%1.09M

101.17%5.17K

-69.35%1.02M

-67.86%1.22M

-16.83%1.34M

-58.21%-441.71K

435.34%3.32M

Total composite income

-16.46%69.78M

-4.76%348.1M

-0.94%257.83M

0.22%191.86M

6.87%83.53M

3.17%365.51M

1.77%260.28M

11.93%191.43M

10.00%78.16M

16.69%354.29M

Total composite income of parent company owners

-14.84%71.35M

-5.08%346.04M

-2.25%257.28M

0.59%191.47M

5.49%83.78M

4.61%364.55M

3.36%263.19M

11.73%190.35M

11.19%79.42M

14.30%348.48M

Total composite income of minority owners

-522.39%-1.57M

112.98%2.05M

119.00%554.29K

-63.90%390.67K

80.02%-252.02K

-83.43%964.06K

-365.49%-2.92M

64.19%1.08M

-238.00%-1.26M

562.10%5.82M

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified opinion

Auditor

Rong Cheng Certified Public Accountants (Special General Partnership)

	(Q3)Mar 31, 2025	(FY)Dec 31, 2024	(Q9)Sep 30, 2024	(Q6)Jun 30, 2024	(Q3)Mar 31, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023	(Q3)Mar 31, 2023	(FY)Dec 31, 2022
Total operating revenue	0.74%5.17B	3.15%20.47B	4.32%15.41B	2.81%10.31B	6.08%5.14B	1.97%19.85B	3.15%14.78B	7.32%10.02B	4.40%4.84B	10.93%19.46B
Operating revenue	0.74%5.17B	3.15%20.47B	4.32%15.41B	2.81%10.31B	6.08%5.14B	1.97%19.85B	3.15%14.78B	7.32%10.02B	4.40%4.84B	10.93%19.46B
Other operating revenue	----	20.10%72.73M	----	-6.47%24.82M	----	7.03%60.56M	----	3.13%26.54M	----	52.24%56.58M
Total operating cost	1.06%5.07B	3.31%20B	4.26%15.05B	2.64%10.04B	6.07%5.02B	2.19%19.36B	3.36%14.44B	7.54%9.78B	4.38%4.73B	10.73%18.95B
Operating cost	1.14%4.81B	3.33%18.95B	4.34%14.28B	2.73%9.53B	6.22%4.76B	2.17%18.34B	3.39%13.69B	7.68%9.28B	4.22%4.48B	10.96%17.95B
Operating tax surcharges	0.96%11.14M	10.58%48.16M	12.99%34.07M	17.29%23.29M	10.78%11.04M	3.04%43.55M	2.34%30.16M	1.16%19.86M	9.95%9.96M	7.81%42.26M
Operating expense	1.65%116.72M	5.94%467.94M	5.02%341.69M	2.79%224.48M	8.84%114.82M	2.07%441.71M	5.03%325.35M	7.49%218.38M	6.21%105.49M	14.09%432.77M
Administration expense	0.58%78.46M	3.87%321.24M	4.89%234.67M	1.79%154.21M	3.65%78.01M	3.51%309.28M	1.33%223.74M	4.31%151.49M	7.85%75.26M	-7.17%298.78M
Financial expense	-7.01%49.04M	-5.06%211.63M	-6.99%155.39M	-6.81%103.16M	-8.91%52.73M	1.30%222.91M	0.77%167.06M	1.58%110.7M	8.13%57.89M	15.01%220.05M
-Interest expense (Financial expense)	-5.50%47.98M	-7.26%206.68M	1.29%152.95M	0.27%101.71M	-0.47%50.78M	1.71%222.85M	1.08%151M	3.24%101.44M	8.70%51.02M	15.15%219.1M
-Interest Income (Financial expense)	82.31%-184.1K	25.37%-3.84M	17.61%-3.01M	44.08%-2.1M	16.62%-1.04M	-33.27%-5.14M	11.67%-3.66M	-48.82%-3.75M	-34.98%-1.25M	25.53%-3.86M
Research and development	12.15%1.37M	5.63%5.85M	28.23%3.64M	41.26%2.74M	58.31%1.22M	33.47%5.53M	-0.77%2.84M	38.41%1.94M	27.61%769.3K	39.51%4.15M
Credit Impairment Loss	28.66%-8.76M	94.47%-813.09K	4.17%-17.52M	-35.85%-14.86M	-2.20%-12.28M	70.15%-14.71M	13.57%-18.28M	24.51%-10.94M	-17.29%-12.02M	-57.46%-49.3M
Asset Impairment Loss	79.07%-120.43K	27.36%-1.87M	49.98%-289.95K	227.46%418.83K	-426.72%-575.39K	17.53%-2.58M	88.66%-579.62K	92.46%-328.6K	95.94%-109.24K	55.64%-3.13M
Other net revenue	14.24%-12.71M	33.74%-11.61M	-56.48%-25.44M	-140.57%-18.06M	-26.33%-14.81M	65.76%-17.53M	34.44%-16.25M	58.61%-7.51M	4.32%-11.73M	-67.33%-51.19M
Fair value change income	----	----	----	----	----	----	----	----	--0	----
Invest income	-42.39%-5.06M	-54.09%-18.73M	-167.53%-12.98M	-459.42%-9.31M	-37.48%-3.55M	-75.66%-12.16M	-95.55%-4.85M	-17.43%-1.66M	-577.61%-2.58M	-224.12%-6.92M
Net open hedge income	----	----	----	----	----	----	----	----	--0	----
-Including: Investment income associates	---1.64M	-2,709.17%-4.33M	-320.97%-3.22M	---2.45M	----	-117.01%-154.29K	--1.46M	--0	--0	--906.8K
Asset deal income	132.66%1.18K	-37.56%172.33K	158.46%67.99K	83.41%-25.15K	79.01%-3.61K	117.85%275.98K	-193.17%-116.29K	-214.01%-151.56K	-124.56%-17.21K	123.78%126.69K
Other revenue	-22.87%1.23M	-17.30%9.63M	-30.23%5.29M	2.60%5.72M	-46.78%1.6M	45.10%11.65M	97.82%7.58M	179.22%5.58M	202.17%3M	-23.08%8.03M
Operating profit	-12.24%92.6M	-2.23%458.1M	4.57%337.19M	5.48%245.22M	4.21%105.52M	0.56%468.56M	-2.66%322.45M	3.73%232.48M	6.53%101.26M	14.80%465.94M
Add:Non operating Income	276.16%927.43K	70.57%4.52M	10.94%1.36M	-4.26%1.12M	44.74%246.55K	-33.82%2.65M	-49.84%1.23M	-39.96%1.17M	-79.99%170.34K	-66.67%4.01M
Less:Non operating expense	332.83%982.79K	423.12%9.35M	409.21%4.75M	81.57%1.18M	7.31%227.06K	-54.66%1.79M	1.25%932.76K	29.82%651.06K	28.10%211.6K	46.46%3.94M
Total profit	-12.31%92.55M	-3.44%453.27M	3.43%333.8M	5.22%245.15M	4.27%105.54M	0.73%469.42M	-3.02%322.74M	3.29%233M	5.72%101.22M	12.23%466.01M
Less:Income tax cost	3.51%22.79M	0.62%105.58M	19.19%75.9M	26.77%54.39M	-2.67%22.02M	-8.79%104.93M	-21.21%63.68M	-23.58%42.9M	-7.32%22.62M	4.01%115.04M
Net profit	-16.49%69.76M	-4.61%347.7M	-0.45%257.9M	0.35%190.76M	6.26%83.52M	3.85%364.49M	2.82%259.06M	12.20%190.1M	10.19%78.6M	15.22%350.97M
Net profit from continuing operation	-16.49%69.76M	-4.61%347.7M	-0.45%257.9M	0.35%190.76M	6.26%83.52M	3.85%364.49M	2.82%259.06M	12.20%190.1M	10.19%78.6M	15.22%350.97M
Less:Minority Profit	-522.39%-1.57M	112.98%2.05M	119.00%554.29K	-63.90%390.67K	80.02%-252.02K	-83.43%964.06K	-365.49%-2.92M	64.19%1.08M	-238.00%-1.26M	562.10%5.82M
Net profit of parent company owners	-14.86%71.32M	-4.92%345.64M	-1.77%257.35M	0.72%190.37M	4.90%83.78M	5.32%363.53M	4.43%261.98M	12.00%189.01M	11.37%79.86M	12.84%345.16M
Earning per share
Basic earning per share	-18.18%0.18	-5.32%0.89	-1.49%0.66	0.00%0.49	4.76%0.22	5.62%0.94	3.08%0.67	13.95%0.49	16.67%0.21	12.66%0.89
Diluted earning per share	----	----	-1.49%0.66	----	----	----	--0.67	----	----	----
Other composite income	351.01%23.34K	-60.91%397.85K	-105.58%-67.89K	-18.11%1.09M	101.17%5.17K	-69.35%1.02M	-67.86%1.22M	-16.83%1.34M	-58.21%-441.71K	435.34%3.32M
Other composite income of parent company owners	351.01%23.34K	-60.91%397.85K	-105.58%-67.89K	-18.11%1.09M	101.17%5.17K	-69.35%1.02M	-67.86%1.22M	-16.83%1.34M	-58.21%-441.71K	435.34%3.32M
Total composite income	-16.46%69.78M	-4.76%348.1M	-0.94%257.83M	0.22%191.86M	6.87%83.53M	3.17%365.51M	1.77%260.28M	11.93%191.43M	10.00%78.16M	16.69%354.29M
Total composite income of parent company owners	-14.84%71.35M	-5.08%346.04M	-2.25%257.28M	0.59%191.47M	5.49%83.78M	4.61%364.55M	3.36%263.19M	11.73%190.35M	11.19%79.42M	14.30%348.48M
Total composite income of minority owners	-522.39%-1.57M	112.98%2.05M	119.00%554.29K	-63.90%390.67K	80.02%-252.02K	-83.43%964.06K	-365.49%-2.92M	64.19%1.08M	-238.00%-1.26M	562.10%5.82M
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	--	Unqualified opinion	--	--	--	Unqualified opinion	--	--	--	Unqualified opinion
Auditor	--	Rong Cheng Certified Public Accountants (Special General Partnership)	--	--	--	Rong Cheng Certified Public Accountants (Special General Partnership)	--	--	--	Rong Cheng Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

002788 Luyan Pharma

Luyan Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Market Insights

Discussing

Latest News

Investment Course